… Hanne F Harbo has received speaking honoraria and support of travel expenses for
scientific meetings from Novartis, Sanofi-Aventis and Biogen Idec, Norway. Ralf Gold received …

Multiple sclerosis (MS) is a prevalent inflammatory disease of the central nervous system that
often leads to disability in young adults. Treatment options are limited and often only partly …

Objectives – Multiple sclerosis (MS) likely results from an interaction between genetic and
exogenous factors. While genetics shapes the overall population MS susceptibility, observed …

Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting
more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of …

Common risk factors for psychiatric and other brain disorders are likely to converge on biological
pathways influencing the development and maintenance of brain structure and function …

Genetic risk for multiple sclerosis (MS) is thought to involve both common and rare risk alleles.
Recent GWAS and subsequent meta-analysis have established the critical role of the HLA …

Converging evidence implicates immune abnormalities in schizophrenia (SCZ), and recent
genome-wide association studies (GWAS) have identified immune-related single-nucleotide …

Objective: The objective of this study is to comprehensively define the genetic basis of early
onset myasthenia gravis (EOMG). Methods: We have carried out a 2‐stage genome‐wide …

The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for
multiple sclerosis (MS). Here, we find that DRB1*15:01 is hypomethylated and predominantly …

In order to analyze whether loci in the human leukocyte antigen (HLA) class I region may
contribute to the HLA class II‐associated genetic susceptibility to multiple sclerosis (MS), we …